Dear Colleagues,  The Strategic Advisory Group of Experts on Immunization (SAGE) of the World Health Organization is seeking qualified experts to serve on a SAGE Working Group on yellow fever vaccination yellow fever SAGE Working Group on yello...

The next edition of the Target product profile (TPP) for yellow fever (YF) assays has been posted on 3rd February 2025 for public consultation HERE and will be open for the next 28 days (closing date 3rd March 2025). This public consultation is part of the normal WHO d...

Dear Colleagues, I would like to bring to your attention that the Summary Tables of WHO Routine Immunization Recommendations have been updated. The latest versions (November 2021) of the Summary Tables (available in both FRENCH and ENGLISH) can be downloaded from the WHO website (htt...

Recent reports [1] of counterfeit yellow fever vaccination certificates in Zambia follow reports of falsified proof of vaccination documents being used in other countries, including Ethiopia [2], India [3], Nigeria [4], Pakistan [5], Sudan [6], Uganda [7], Tanzania [8] and Zimbabwe [9]. While the Wo...

I am really interested in the potential benefits that blockchain technology could bring to immunization. There have been many discussions on vaccine packaging and barcoding as I can recall, and I was wondering if blockchain technology was mentioned (or even central now!) during t...

-------------------------------------------------------------------------------------------------------------------------------------------------------------------- proof / prüf / (noun) 1. evidence or argument establishing or helping to establish a fact or the truth of a statement synonyms: evid...

Dear all, Can anyone have an idea on the scientific basis for the use of the fractional dose (0.1 ml) of Yellow Fever vaccine during a pre-emptive mass vaccination campaign? As a reminder, in August 2016, the congolese health authorities in collaboration with WHO and CDC launched a preventive mass...

Hello All, In the website for WHO PQ vaccines BCG and Yellow Fever are the two vaccines which have multi dose preparations packaged in ampoules. As soon as we open a mulit-dose ampoule and administer the first dose, we are leaving the remining doses in the ampoule exposed to environment (very often...

Joanie Robertson Senior Manager, Vaccine Supply Chain, GAVI Alliance wants your views on vaccine investment strategies and the vaccine supply chain. The GAVI Alliance is currently developing two strategies, and your views are important for both. The Vaccine Investment Strategy and the Supply Chain...

A recently published paper (JB Milstien and M Kaddar. 'The role of emerging manufacturers in access to innovative vaccines of public health importance', Vaccine 28: 2115-2121, 2010) analyzes the potential for emerging suppliers, those vaccine manufacturers located in developing countries, to supply ...

Temperature Monitoring Study To Commence in Vietnam and Uganda by Joanie Robertson, Huong Vu and James Cheyne, PATH While some vaccines will lose their potency if they are stored at temperatures above or below the standard 2° to 8°C, many vaccines are quite heat stable and can tolerate temperatures...

POST 01117E : VVM ANNIVERSARY Follow-up on Posts 01101E and 01106E 5 July 2007 _____________________________________ Ãœmit Kartoglu from WHO/HQ replies to [log in to unmask]">Robert [log in to unmask]">Steinglass _____________________________________ Dear Robert, ...

POST 01111E : WASTE MANAGEMENT 23 June 2007 _____________________________________ [log in to unmask]">Modibo [log in to unmask]"> Dicko, from WHO/AFRO, shares two interesting documents on waste management with his analysis and conclusions. Hyperlinks below will give access to r...

POST 01094E : YELLOW FEVER INITIATIVE 18 May 2007 ____________________________________ Global health partners mobilize to counter yellow fever US$ 58 million GAVI contribution to prevent highly contagious disease in 12 West African nations 16 May 2007, Geneva ; The effort to contain th...

POST 01068E : TEMPERATURE MONITORING DEVICES INTERPRETATION 23 March 2007 ____________________________________ Dear all, According to WHO Guidelines on the international packaging and shipping of vaccines (WHO/IVB/05.23) a 10-day electronic temperature monitoring device should be inc...

POST 01051E : USE OF ALCOHOL FOR VACCINE INJECTIONS Follow-up on Posts 01029E, 01036E and 01044E 8 February 2007 ________________________________________ This posting contains three contributions. I believe that this will likely settle the issue. The first is from Serge Ganivet (mail...

POST 00869E : COMBINATION VACCINES, LYOPHILIZED VACCINES, DILUENTS AND VVMS Follow-up on Posts 00847E, 00852E, 00855E, 00858E, 00860E and 00864E 26 December 2005 _____________________________________ Michel Zaffran (mailto:[email protected]) from WHO draws some conclusions from this dis...

POST 00772E : EXPANSION OF AFP SURVEILLANCE 6 April 2005 _____________________________________ NOTE : This posting had been sent at the beginning of March but server's problems prevented its distribution. Bob Davis (mailto:[email protected]) from UNICEF/ESARO draws our attention to an ar...

POST 00528E : VACCINE WASTAGE 5 December 2002 _________________________________________________________________________________ Ãœmit Kartoglu (mailto:[log in to unmask]) from WHO would appreciate comments on a document that he has written on Vaccine Wastage and submits here for review. Thi...

POST 00494E : PROTECTION OF MORE COLD-SENSITIVE VACCINES Follow-up on Posts 00400E, 00412E, 00419E, 00428E, 00475E, 00480E, 00482E, 00484E, 00490E and 00491E 31 August 2002 ______________________________________________________________ Anthony Battersby (mailto:[log in to unmask]) from F...